Home/Filings/4/0001209191-17-049892
4//SEC Filing

Krell Elizabeth D 4

Accession 0001209191-17-049892

CIK 0001323885other

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 9:08 AM ET

Size

8.8 KB

Accession

0001209191-17-049892

Insider Transaction Report

Form 4
Period: 2017-08-21
Transactions
  • Sale

    Common Stock

    2017-08-22$22.40/sh10,000$224,00019,967 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-08-2110,0000 total
    Exercise: $8.04From: 2013-05-15Exp: 2022-05-15Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2017-08-21$8.04/sh+10,000$80,40029,967 total
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $22.35 to $22.52 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]These options were granted on May 15, 2012 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1
  • filerCIK 0001367742

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 9:08 AM ET
Size
8.8 KB